Zavondemstat

(Synonyms: QC8222 free base; TACH 101 free base)
1 Cited Publications
Customer Review

Based on 1 publication(s) in Google Scholar

Zavondemstat (QC8222 free base; TACH 101 free base) is an orally active pan-KDM4 and DHODH inhibitor. Zavondemstat inhibits KDM4A, KDM4B, KDM4C and KDM4D with IC50 values ≤0.080 µM, and exhibits an IC50 of 0.6 nM against human DHODH. Zavondemstat inhibits the KDM4C histone demethylase by competing with the α-ketoglutarate cofactor, and targets DHODH in de novo pyrimidine biosynthesis. Zavondemstat induces apoptosis and S-phase cell cycle arrest, reduces the tumor-initiating cell population, and shows broad antiproliferative activity across multiple cancer cell lines and donor-derived organoids. Zavondemstat can be used for research on colorectal cancer, esophageal squamous cell carcinoma, triple-negative breast cancer and glioblastoma.

For research use only. We do not sell to patients.

  • Purity : 99.29%
  • CAS No.: 1851412-93-5
  • Formula: C26H29N3O3
  • Molecular Weight:431.53
  • Storage:

    4°C, protect from light, stored under nitrogen

    * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

  • Biological Activity
  • Chemical Information
  • Solvent & Solubility
  • Protocols
  • Purity & Documentation
  • References
  • Help & FAQs

Publications Citing Use of MedChemExpress (MCE) Zavondemstat

More

All Histone Demethylase Isoforms

More
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00